835
Participants
Start Date
February 22, 2022
Primary Completion Date
January 10, 2023
Study Completion Date
January 10, 2023
24 valent pneumococcal conjugate vaccine
0.5 ml dose of VAX-24 will be administered into the deltoid muscle at Day 1
20 valent pneumococcal conjugate vaccine
0.5 ml dose of PCV20 will be administered into the deltoid muscle at Day 1
Rochester Clinical Research, Rochester
Acellacare of Wilmington, Wilmington
Coastal Carolina Research, North Charleston
Meridian Clinical Research, Savannah
CenExel RCA, Hollywood
Precision Clinical Research, Sunrise
Velocity Clinical Research, Valparaiso
Alliance for Multispecialty Research, Kansas City
Johnson County Clin-Trials, Lenexa
Benchmark Research, Metairie
Benchmark Research, San Angelo
JBR Clinical Research, Salt Lake City
Velocity Clinical Research, Warwick
Vaxcyte, Inc.
INDUSTRY